Little J M, Richey J E, Van Thiel D H, Lester R
J Clin Invest. 1979 May;63(5):1042-9. doi: 10.1172/JCI109373.
Taurocholate concentrations in fetal and neonatal rats were determined by radioimmunoassay. Total body taurocholate pool size varied from 0.0049 +/- 0.0008 to 203 +/- 8 nmol/g body weight from day 5 of gestation to 5 d after birth. A 50-fold increase in taurocholate pool size was observed between days 15 and 19 of gestation. The distribution of taurocholate between liver, intestine, and the remainder of the carcass was determined for rats of gestational age 19 d to 5 d after birth. The major fraction of total body taurocholate was in the liver and intestine, with less than 15% in the remainder of the carcass. The ratio of taurocholate in intestine to taurocholate in liver, which was 1:17 at 19 d of gestation, had altered substantially to a ratio of 6:1 by 5 d after birth. Treatment of pregnant rats with 60 microgram/d of dexamethasone from gestational day 9 until sacrifice increased fetal taurocholate pool size by 80% at 15 d, 40% at 19 d, and 16% at 1 d after birth. Administration of dexamethasone to the mother also changed the ratio of taurocholate in intestine to taurocholate in liver. At 19 d of gestation, dexamethasone-treated mothers had fetuses with approximately equal amounts of taurocholate in intestine and liver. This suggested that adrenocorticosteroids stimulate the early maturation of factors controlling taurocholate pool size and tissue distribution in the rat fetus.
采用放射免疫分析法测定了胎鼠和新生鼠体内的牛磺胆酸盐浓度。从妊娠第5天到出生后5天,全身牛磺胆酸盐池大小从0.0049±0.0008 nmol/g体重变化到203±8 nmol/g体重。在妊娠第15天到19天期间,观察到牛磺胆酸盐池大小增加了50倍。测定了妊娠19天至出生后5天的大鼠肝脏、肠道和胴体其余部分中牛磺胆酸盐的分布情况。全身牛磺胆酸盐的主要部分存在于肝脏和肠道中,胴体其余部分中的含量不到15%。肠道中牛磺胆酸盐与肝脏中牛磺胆酸盐的比例在妊娠19天时为1:17,到出生后5天时已大幅改变为6:1。从妊娠第9天至处死,用60微克/天的地塞米松处理妊娠大鼠,结果在妊娠15天时胎儿牛磺胆酸盐池大小增加了80%,在妊娠19天时增加了40%,在出生后1天时增加了16%。给母体注射地塞米松也改变了肠道中牛磺胆酸盐与肝脏中牛磺胆酸盐的比例。在妊娠19天时,经地塞米松处理的母体所生胎儿的肠道和肝脏中牛磺胆酸盐含量大致相等。这表明肾上腺皮质类固醇可刺激大鼠胎儿中控制牛磺胆酸盐池大小和组织分布的因子的早期成熟。